Bone Complications Among Prostate Cancer Survivors Having Prolonged Hormone Therapy (ADT)
Androgen deprivation therapy (ADT) and bone complications are the two near universals for men with advanced prostate cancer. A long-term follow up of fifteen (15) years after diagnosis of a population-based cohort of prostate cancer [...]
Xofigo To Again Be Available to New Patients with Metastatic Prostate Cancer
Bayer Healthcare has announced that they will be resuming production of Xofigo® (radium Ra 223 dichloride) for new patients beginning on Monday, November 17th. Xofigo is the newly FDA approved radiopharmaceutical treatment for men with [...]
Dendreon Files for Chapter 11 Voluntary Bankruptcy Reorganization – Production Continues
It was announced this morning that Dendreon (the manufactures of Provenge) has filed for voluntary Chapter 11 Bankruptcy. After having spoken with a representative at Dendreon I have learned that the company has been in [...]
Doctoral Student Develops A Device That Provides An Up-Close Look At Cancer’s Movement In The Body
Sometimes scientific research is amazing! We are so lucky to have so many brilliant and gifted young people interested in conquering cancer. One of these brilliant young people is a doctoral student at Johns Hopkins, [...]
Agent Orange Exposure? Your Children & Grandchildren Might Be At Risk!
A large number of the readers of this blog either have had exposure to Agent Orange or have family members who have had the exposure. We know that for those men exposed their risks for [...]
Long-Term Results of COU-AA-302 Show Abiraterone (Zytiga) Has A Survival Benefit
When the FDA approved Abiraterone with prednisone (Zytiga) in the pre-chemotherapy stage they approved it after an interim analysis of data was performed of the phase III clinical trial (COU-AA-302), The analysis was performed by [...]